Background and Aims
This study aimed to investigate whether AI via a deep learning algorithm using endoscopic ultrasonography (EUS) images could predict the malignant potential of gastric gastrointestinal stromal tumors (GISTs).
A series of patients who underwent EUS before surgical resection for gastric GISTs were included. A total of 685 images of GISTs from 55 retrospectively included patients were used as the training data set for the AI system. Convolutional neural networks were constructed to build a deep learning model. After applying the synthetic minority oversampling technique, 70% of the generated images were used for AI training and 30% were used to test AI diagnoses. Next, validation was performed using 153 EUS images of 15 patients with GISTs. In addition, conventional EUS features of 55 patients in the training cohort were evaluated to predict the malignant potential of GISTs and mitotic index.
The overall sensitivity, specificity, and accuracy of the AI system for predicting malignancy risk were 83%, 94%, and 82% in the training dataset, and 75%, 73%, and 66% in the validation cohort, respectively. When patients were divided into low-risk and high-risk groups, sensitivity, specificity, and accuracy increased to 99% in the training dataset and 99.7%, 99.7%, and 99.6%, respectively, in the validation cohort. No conventional EUS features were found to be associated with either malignant potential or mitotic index (P > 0.05).
AI via a deep learning algorithm using EUS images could predict the malignant potential of gastric GISTs with high accuracy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Armed Forces Institute of Pathology
Artificial neural network
Convolutional neural network
Fine needle aspiration
Gastrointestinal stromal tumor
Negative predictive value
Positive predictive value
Receiver Operating Characteristic
Synthetic minority oversampling technique
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52–68. https://doi.org/10.1097/01.pas.0000146010.92933.de.
Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol 2016;40:39–46. https://doi.org/10.1016/j.canep.2015.10.031.
Baysal B, Masri OA, Eloubeidi MA, Senturk H. The role of EUS and EUS-guided FNA in the management of subepithelial lesions of the esophagus: a large, single-center experience. Endosc Ultrasound 2017;6:308–316. https://doi.org/10.4103/2303-9027.155772.
Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep 2011;13:532–539. https://doi.org/10.1007/s11894-011-0224-6.
Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–465. https://doi.org/10.1053/hupa.2002.123545.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70–83. https://doi.org/10.1053/j.semdp.2006.09.001.
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008;39:1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025.
Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477–489. https://doi.org/10.1097/00000478-200604000-00008.
Larghi A, Fuccio L, Chiarello G, Attili F, Vanella G, Paliani GB et al. Fine-needle tissue acquisition from subepithelial lesions using a forward-viewing linear echoendoscope. Endoscopy 2014;46:39–45. https://doi.org/10.1055/s-0033-1344895.
Polkowski M, Gerke W, Jarosz D, Nasierowska-Guttmejer A, Rutkowski P, Nowecki ZI et al. Diagnostic yield and safety of endoscopic ultrasound-guided trucut [corrected] biopsy in patients with gastric submucosal tumors: a prospective study. Endoscopy 2009;41:329–334. https://doi.org/10.1055/s-0029-1214447.
Ricci R, Chiarello G, Attili F, Fuccio L, Alfieri S, Persiani R et al. Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours. Dig Liver Dis 2015;47:291–295. https://doi.org/10.1016/j.dld.2014.12.011.
Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37–43. https://doi.org/10.1067/mge.2002.120323.
Okubo K, Yamao K, Nakamura T, Tajika M, Sawaki A, Hara K et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 2004;39:747–753. https://doi.org/10.1007/s00535-004-1383-0.
Seven G, Kochan K, Caglar E, Kiremitci S, Koker IH, Senturk H. Evaluation of Ki67 index in endoscopic ultrasound-guided fine needle aspiration samples for the assessment of malignancy risk in gastric gastrointestinal stromal tumors. Dig Dis. 2020. https://doi.org/10.1159/000511994.
Cağlar E, Hatemi I, Atasoy D, Sişman G, Sentürk H. Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions. Clin Endosc 2013;46:379–383. https://doi.org/10.5946/ce.2013.46.4.379.
Wani S, Muthusamy VR, Komanduri S. EUS-guided tissue acquisition: an evidence-based approach (with videos). Gastrointest Endosc 2014;80:939–59.e7. https://doi.org/10.1016/j.gie.2014.07.066.
Jeon SW, Park YD, Chung YJ, Cho CM, Tak WY, Kweon YO et al. Gastrointestinal stromal tumors of the stomach: endosonographic differentiation in relation to histological risk. J Gastroenterol Hepatol 2007;22:2069–2075. https://doi.org/10.1111/j.1440-1746.2006.04767.x.
Shah P, Gao F, Edmundowicz SA, Azar RR, Early DS. Predicting malignant potential of gastrointestinal stromal tumors using endoscopic ultrasound. Dig Dis Sci 2009;54:1265–1269. https://doi.org/10.1007/s10620-008-0484-7.
Chen TH, Hsu CM, Chu YY, Wu CH, Chen TC, Hsu JT et al. Association of endoscopic ultrasonographic parameters and gastrointestinal stromal tumors (GISTs): can endoscopic ultrasonography be used to screen gastric GISTs for potential malignancy? Scand J Gastroenterol 2016;51:374–377. https://doi.org/10.3109/00365521.2015.1095350.
Chen T, Xu L, Dong X, Li Y, Yu J, Xiong W et al. The roles of CT and EUS in the preoperative evaluation of gastric gastrointestinal stromal tumors larger than 2 cm. Eur Radiol 2019;29:2481–2489. https://doi.org/10.1007/s00330-018-5945-6.
Brand B, Oesterhelweg L, Binmoeller KF, Sriram PV, Bohnacker S, Seewald S et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 2002;34:290–297. https://doi.org/10.1016/s1590-8658(02)80150-5.
Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468–473. https://doi.org/10.1016/s0016-5107(97)70175-5.
Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smaïl-Tabbone M et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology 2020;158:76-94.e2. https://doi.org/10.1053/j.gastro.2019.08.058.
Kuwahara T, Hara K, Mizuno N, Okuno N, Matsumoto S, Obata M et al. Usefulness of deep learning analysis for the diagnosis of malignancy in intraductal papillary mucinous neoplasms of the pancreas. Clin Transl Gastroenterol 2019;10:1–8. https://doi.org/10.14309/ctg.0000000000000045.
Kurita Y, Kuwahara T, Hara K, Mizuno N, Okuno N, Matsumoto S et al. Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions. Sci Rep 2019;9:6893. https://doi.org/10.1038/s41598-019-43314-3.
Maeda Y, Kudo SE, Mori Y, Misawa M, Ogata N, Sasanuma S et al. Fully automated diagnostic system with artificial intelligence using endocytoscopy to identify the presence of histologic inflammation associated with ulcerative colitis (with video). Gastrointest Endosc 2019;89:408–415. https://doi.org/10.1016/j.gie.2018.09.024.
Horie Y, Yoshio T, Aoyama K, Yoshimizu S, Horiuchi Y, Ishiyama A et al. Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks. Gastrointest Endosc 2019;89:25–32. https://doi.org/10.1016/j.gie.2018.07.037.
Zhu Y, Wang QC, Xu MD, Zhang Z, Cheng J, Zhong YS et al. Application of convolutional neural network in the diagnosis of the invasion depth of gastric cancer based on conventional endoscopy. Gastrointest Endosc 2019;89:806–15.e1. https://doi.org/10.1016/j.gie.2018.11.011.
Goodfellow I. Deep learning. Cambridge: MIT Press; 2016.
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 2018;16:536–563. https://doi.org/10.6004/jnccn.2018.0025.
Joo MK, Park JJ, Kim H, Koh JS, Lee BJ, Chun HJ et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract. Gastrointest Endosc 2016;83:318–326. https://doi.org/10.1016/j.gie.2015.07.034.
Kim GH, Choi KD, Gong CS, Lee IS, Park YS, Han M et al. Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case–control study. Gastrointest Endosc 2020;91:527–536. https://doi.org/10.1016/j.gie.2019.10.020.
Conflict of interest
The authors have no conflicts of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Seven, G., Silahtaroglu, G., Kochan, K. et al. Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors. Dig Dis Sci (2021). https://doi.org/10.1007/s10620-021-06830-9
- Artificial intelligence
- Gastric gastrointestinal stromal tumors
- Mitotic index
- Risk classification